tradingkey.logo
tradingkey.logo
Search

Hims & Hers Health Inc

HIMS
Add to Watchlist
25.325USD
-3.815-13.09%
Market hours ETQuotes delayed by 15 min
5.75BMarket Cap
44.38P/E TTM

Hims & Hers Health Inc

25.325
-3.815-13.09%

More Details of Hims & Hers Health Inc Company

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.

Hims & Hers Health Inc Info

Ticker SymbolHIMS
Company nameHims & Hers Health Inc
IPO dateSep 09, 2019
CEODudum (Andrew)
Number of employees1637
Security typeOrdinary Share
Fiscal year-endSep 09
Address2269 Chestnut St
CitySAN FRANCISCO
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code94123
Phone14158510195
Websitehttps://www.forhims.com/
Ticker SymbolHIMS
IPO dateSep 09, 2019
CEODudum (Andrew)

Company Executives of Hims & Hers Health Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.53M
-4.23%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
299.37K
-3.16%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
270.81K
-20.09%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
51.77K
--
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
--
Dr. Patrick Carroll, M.D.
Dr. Patrick Carroll, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Dr. Delos Cosgrove, M.D.
Dr. Delos Cosgrove, M.D.
Independent Director
Independent Director
--
--
Ms. Andrea Perez
Ms. Andrea Perez
Independent Director
Independent Director
--
--
Mr. David Wells
Mr. David Wells
Lead Independent Director
Lead Independent Director
--
--
Mr. Mike Chi
Mr. Mike Chi
Chief Operating Officer
Chief Operating Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.53M
-4.23%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
299.37K
-3.16%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
270.81K
-20.09%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
51.77K
--
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
--
Dr. Patrick Carroll, M.D.
Dr. Patrick Carroll, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
By BusinessUSD
Name
Revenue
Proportion
Online
2.31B
98.46%
Wholesale
36.19M
1.54%
By RegionUSD
Name
Revenue
Proportion
United States Revenue
2.21B
94.29%
Rest of the World Revenue
133.99M
5.71%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Online
2.31B
98.46%
Wholesale
36.19M
1.54%

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
10.40%
JP Morgan Asset Management
6.74%
Capital World Investors
6.43%
Vanguard Portfolio Management, LLC
4.57%
Goldman Sachs & Company, Inc.
4.38%
Other
67.48%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
10.40%
JP Morgan Asset Management
6.74%
Capital World Investors
6.43%
Vanguard Portfolio Management, LLC
4.57%
Goldman Sachs & Company, Inc.
4.38%
Other
67.48%
Shareholder Types
Shareholders
Proportion
Investment Advisor
49.41%
Investment Advisor/Hedge Fund
12.84%
Research Firm
10.91%
Hedge Fund
6.28%
Individual Investor
5.42%
Bank and Trust
1.84%
Pension Fund
1.83%
Sovereign Wealth Fund
0.86%
Private Equity
0.14%
Other
10.46%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
1130
208.41M
93.60%
-37.99M
2025Q4
1061
210.10M
95.82%
-8.20M
2025Q3
970
195.39M
89.11%
-889.66K
2025Q2
893
201.00M
92.37%
-34.62M
2025Q1
847
185.19M
85.97%
-48.88M
2024Q4
739
195.19M
91.41%
-9.62M
2024Q3
627
167.49M
80.36%
-35.34M
2024Q2
588
165.89M
79.48%
-12.74M
2024Q1
503
156.70M
75.98%
-10.05M
2023Q4
463
153.90M
75.37%
-26.71M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
23.16M
10.55%
+1.08M
+4.88%
Dec 31, 2025
JP Morgan Asset Management
15.00M
6.83%
+2.13M
+16.55%
Dec 31, 2025
Capital World Investors
14.32M
6.52%
-4.46M
-23.75%
Dec 31, 2025
Goldman Sachs & Company, Inc.
9.76M
4.44%
+1.22M
+14.23%
Dec 31, 2025
Dudum (Andrew)
9.93M
4.52%
-362.12K
-3.52%
Mar 13, 2026
State Street Investment Management (US)
7.31M
3.33%
+132.31K
+1.84%
Dec 31, 2025
Geode Capital Management, L.L.C.
5.51M
2.51%
+608.95K
+12.43%
Dec 31, 2025
Renaissance Technologies LLC
4.82M
2.19%
-4.28M
-47.04%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
First Trust Nasdaq Lux Digi Health Solutions ETF
3.83%
Global X HealthTech ETF
3.75%
Amplify Weight Loss Drug & Treatment ETF
3.67%
Invesco Dorsey Wright Healthcare Momentum ETF
3.66%
YieldMax Ultra Option Income Strategy ETF
2.96%
Invesco S&P MidCap 400 Pure Growth ETF
2.4%
State Street SPDR S&P Health Care Services ETF
1.94%
Amplify Online Retail ETF
1.85%
Invesco S&P MidCap 400 GARP ETF
1.65%
VanEck Social Sentiment ETF
1.53%
View more
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion3.83%
Global X HealthTech ETF
Proportion3.75%
Amplify Weight Loss Drug & Treatment ETF
Proportion3.67%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion3.66%
YieldMax Ultra Option Income Strategy ETF
Proportion2.96%
Invesco S&P MidCap 400 Pure Growth ETF
Proportion2.4%
State Street SPDR S&P Health Care Services ETF
Proportion1.94%
Amplify Online Retail ETF
Proportion1.85%
Invesco S&P MidCap 400 GARP ETF
Proportion1.65%
VanEck Social Sentiment ETF
Proportion1.53%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI